Intuitive Surgical Inc (ISRG) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Intuitive Surgical Inc   (NASDAQ: ISRG)


Intuitive Surgical Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Intuitive Surgical Inc 's ROA in the second quarter of 2026?
Intuitive Surgical Inc achieved a return on average assets (ROA) of 15.53 % in its second quarter of 2026, this is above ISRG's average return on assets of 14.44%.
Intuitive Surgical Inc s assets during the 12 months ending in the second quarter of 2026 are valued at $20 billion

Despite the company's net income deteriorating, Intuitive Surgical Inc was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector 63 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 355, from total ROA ranking in the first quarter of 2026 at 421.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 6.12 % 4.62 % 9.15 % 9.06 % 21.1 %
Y / Y Net Income Change 23.94 % 17.38 % 16.21 % 24.29 % 24.97 %
Net Income (TTM) in million 3,158 2,999 2,877 2,765 2,627
Return On Assets (TTM) 15.53 % 14.98 % 14.53 % 14.27 % 13.85 %
ISRG's Total Ranking # 355 # 421 # 385 # 390 # 398
Total Assets (TTM) in million 21,400 20,111 20,459 19,353 20,165
Seq. Total Assets Change 6.41 % -1.7 % 5.71 % -4.03 % 4.9 %
Seq. Net Income Change -0.34 % 3.31 % 12.73 % 6.78 % -5.61 %



Return On Assets Company Ranking
Within: No.
Industry # 13
Sector # 64
Overall # 325

Return On Assets Statistics
High Average Low
23.32 %
14.44 %
10.03 %
(March 31, 2007)   (Dec 31 2022)





Financial Statements
Intuitive Surgical Inc 's Assets $ 21,400 million ISRG's Balance sheet
Intuitive Surgical Inc 's Income $ 823 million Quarterly ISRG's Income Statement
ISRG's Income by Division See ISRG's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 25.68 % 21.38 % 19.01 % -4.28 % 21.36 %
Total Assets in million 23,558 18,744 15,442 12,975 13,555
Y / Y Net Income Change 23.06 % 28.62 % 35.18 % -22.2 % 61.99 %
Net Income in million 2,877 2,338 1,817 1,344 1,728
Annual Return On Assets 12.21 % 12.47 % 11.77 % 10.36 % 12.75 %




Comment on ISRG's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 12.21 %, despite annual net income growth of 23.06 % to $2,876.60 million, from $2,337.50 million a year ago, as ISRG's assets increase to $23,557.90 million, by 23.06 %.


More Return On Assets Ratios
ISRG's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ISRG's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ISRG's Competitors
Subscribers only: Roa for Intuitive Surgical Inc 's Suppliers
Subscribers only: Return On Assets for ISRG's Customers

You may also want to know
ISRG's Roi ISRG's Inventory Turnover Ratio ISRG's Growth Rates ISRG's Dividend Comparisons
ISRG's Profitability Ratios ISRG's Asset Turnover Ratio ISRG's Dividend Growth
ISRG's Roe ISRG's Valuation Ratios ISRG's Financial Strength Ratios ISRG's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Liquidia Corporation  36.30 %
Ironwood Pharmaceuticals inc   34.34 %
Idexx Laboratories Inc  33.61 %
Tg Therapeutics Inc   33.59 %
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %
Mettler toledo International Inc   24.86 %
Medpace Holdings Inc   24.84 %
Caredx Inc   24.81 %
Acadia Pharmaceuticals Inc   24.38 %
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %


Date modified: 2026-07-23T01:57:36+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.